OncBioMune Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.03 |
Market Cap |
$1.77 M |
Shares Outstanding |
295.2 M |
Public Float |
186.69 M |
Address |
11441 Industriplex Boulevard Baton Rouge Louisiana 70809 United States |
Employees | - |
Website | http://www.oncbiomune.com |
Updated | 07/08/2019 |
OncBioMune Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its products include vaccines, PA-OBC, and PGT-RC. The company was founded on March 18, 2005 and is headquartered in Baton Rouge, LA. |